Clinical Trial Update: Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating azacitidine for high-risk myelodysplastic syndromes and acute myeloid leukemia with chromosome 7 or complex cytogenetic abnorm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: King's College London | Conditions: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute | Phase 2 | Status: COMPLETED